Thanks for the great post as usual Mason.
I’d started giving consideration to whether RACE would use a similar approach for PD-1 to how they structured their Proteasome inhibitor cancer synergy/heart safety announcement by singling out Amgen’s Carfilzomib for possible partnership opportunities based on their relatively near-term patent expiry of 2025.
JDP provided a good list of RACE’s recent patent application listing about half a dozen PD-1 inhibitors that are likely being tested in their in-vitro and in-vivo preclinical trials. I was doing a quick check on patent expiry to see if one of them was approaching that patent cliff sooner than other and therefore may be a more obvious target beyond the all-important results of the preclinical trials themselves.
I came across this article about Merck, which had some interesting comments about Merck pursing co-formulations, which is exactly what we shareholders would ideally want to see is a Zantrene-Pembrolizumab (Keytruda) combination. So, it was good to see Merck already entertaining those combination options to extend patent expiry dates. Also, there is a good reference in their possible M&A targets including targeted oncology & mRNA companies.
Can’t wait to see the results from RACE this quarter!
https://www.biospace.com/article/merck-s-davis-scouring-for-deals-in-preparation-for-keytruda-patent-cliff-/
- Forums
- ASX - By Stock
- RAC
- Unlisted Options Transactions
Unlisted Options Transactions, page-195
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
|
|||||
Last
$1.88 |
Change
0.025(1.35%) |
Mkt cap ! $319.4M |
Open | High | Low | Value | Volume |
$1.85 | $1.89 | $1.85 | $74.38K | 39.92K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 18943 | $1.85 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.88 | 199 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 18943 | 1.850 |
1 | 2500 | 1.830 |
2 | 987 | 1.820 |
8 | 16776 | 1.800 |
1 | 11000 | 1.780 |
Price($) | Vol. | No. |
---|---|---|
1.875 | 199 | 1 |
1.895 | 3000 | 1 |
1.940 | 5148 | 2 |
1.950 | 12000 | 1 |
1.990 | 4701 | 2 |
Last trade - 16.10pm 17/07/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |